Welcome to the SUFU Center of Excellence

Stephen R. Kraus | December 05, 2019

The Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Center of Excellence in collaboration with UroToday has been developed to engage providers on issues in Female Pelvic Medicine & Reconstructive Surgery (FPMRS), urinary incontinence, neurogenic bladder, and complex voiding disorders.  

Our first focus will be on overactive bladder (OAB) and use the SUFU OAB clinical care pathway (CCP) when treating overactive bladder. We determined some time ago that there was not a standardized OAB clinical care pathway. There are variations in the offerings of OAB treatments across practices. We developed an evidence-based expert consensus SUFU OAB Clinical Care Pathway.


Petros Grivas, MD

Stephen R. Kraus, MD is Professor and Interim Chairman of the Department of Urology at the University of Texas Health Science Center at San Antonio where he heads the Division of Female Urology, Neuro - Urology and Voiding Dysfunction. A Fellow of the American College of Surgeons, Dr. Kraus is also a member of: the American Urological Association, the Geriatric Urology Society, the American Urogynecologic Society, the International Continence Society and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU). He is on the Board of Directors for the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) and for the Texas Urological Society where he also serves as Chair of the Education Committee. Dr. Kraus has served as faculty for many postgraduate courses on topics including Neurourology, Female Urology, Overactive Bladder, Male Incontinence & Voiding Disorders, and Urodynamics. In addition, Dr. Kraus served on the AUA Guidelines Panel on Urodynamics and is currently on the AUA Guidelines Panel on Female Stress Urinary Incontinence. Dr. Kraus is actively engaged in research and has served as principal investigator for a variety of studies and research grants including the Urinary Incontinence Treatment Network, sponsored by the NIH/NIDDK. In addition to serving on the editorial board of Drugs and Aging and BMC Urology, Dr. Kraus serves as a reviewer for the Journal of Urology, Urology, and Neurourology & Urodynamics.

Clinical Pathways Resources

SUFU offers the Overactive Bladder Clinical Care Pathway for use by providers and patients
Conference Coverage
Conference Highlights Written by Physician-Scientist
Presented by Diane K. Newman, DNP, CRNP, FAAN, BCB-PMD
This was a retrospective cross-sectional study to examine the clinical and microbiological properties of all women with culture-confirmed singular or sporadic urinary tract infections (sUTI) compared to those with recurrent UTIs (rUTI) in an outpatient female urology practice.
Presented by Stephen Kraus, MD MBA FACS
In 2015, The Society of Urodynamics and Female Urology (SUFU) established a SUFU branded Overactive Bladder (OAB) Clinical Care Project (CCP) with the goal to establish a SUFU branded OAB CCP based on evidence from the American Urology Association (AUA)/SUFU OAB clinical practice guidelines and expert consensus.
Presented by Aidan Kennedy
The aim of this study was to use Amazon MTurk to identify research topics prioritized by patients with overactive bladder (OAB). Amazon MTurk is a crowdsourcing platform. Users were invited to complete a survey on OAB Research.
Presented by Diane K. Newman, DNP, CRNP, FAAN, BCB-PMD
The primary objective of this study was to investigate the disparity of pelvic and genitourinary (GU) exams between male and female patients who present with lower urinary tract symptoms (LUTS), urinary tract infection (UTI), and other urological conditions as well as, assess for predictors of undergoing pelvic examination.
Presented by Diane K. Newman, DNP, CRNP, FAAN, BCB-PMD
The aim of this study is to present a case series of patients who underwent diagnosis and subsequent surgical management of urethral diverticulum (UD). A retrospective study of a prospective database of our urogynecology unit between 2016-2019 identified sixteen patients.
Presented by Diane K. Newman, DNP, CRNP, FAAN, BCB-PMD
The primary aim of this study was to report the percent of patients completing a voiding diary. A secondary aim was to assess what factors may predict diary completion. This was a prospective cohort study of 93 patients undergoing workup for overactive bladder (OAB).
Presented by Nirit Rosenblum, MD
Functionated CO2 vaginal laser therapy is most common in Female Pelvic Medicine and Reconstructive Surgery (FPMRS) practice. It is minimally ablative, shown to be safe, precise, and efficient for skin resurfacing. It destroys the epidermis/dermis in micro treatment zones inducing wound healing.
Presented by Alexandra Rogers, MD
Scottsdale, Arizona (UroToday.com) In this study, an eCoin 2 trial, Dr. Alexandra Rogers aimed in a single arm to evaluate the safety and efficacy of the study device for treating urinary urgency incontinence (UUI) after 12 weeks. Percutaneous tibial nerve stimulation is approved to treat overactive bladder syndrome.
Presented by Angelo Gousse, MD
Scottsdale, AZ (UroToday.com) Dr. Angelo Gousse presented his experience with 2-stage management for complex refractory bladder neck contracture (BNC) after prostate cancer treatment
Presented by Kaitlyn Maddra
Scottsdale, AZ (UroToday.com) Kaitlyn Maddra presents their research on audio-visual stimulation triggering urgency in overactive bladder patients. They aimed to quantify the changes
Presented by Katie C. Bittner
Scottsdale, Arizona (UroToday.com) This study aimed to demonstrate that a new rechargeable, current-controlled sacral neuromodulation (SNM) system (InterStim™ Micro)
Presented by Loren Ketai, MD
Scottsdale, Arizona (UroToday.com) In this presentation the authors hypothesized that hypnotherapy and medication groups would differ in post-treatment brain activation during
Presented by Monique Vaughan, MD
Scottsdale, AZ (UroToday.com) The authors aimed in this cross-sectional study to compare urinary microbes in three groups of menopausal women:1) women with recurrent urinary tract infections
Presented by Jeffrey P. Weiss, MD
Miami, FL (UroToday.com) Dr. Jeffrey Weiss provided an update of the management of nocturia. Patients are oftentimes asked to fill out a 24-hour voiding diary but compliance in completing them is sometimes very difficult to obtain.
Presented by Roger R. Dmochowski, M.D., MMHC
Miami, FL (UroToday.com) Most electrical muscle stimulation devices for the treatment of stress urinary incontinence (SUI)
Presented by Craig Comiter, MD
Miami, FL (UroToday.com) Although uroflowmetry is a frequently used diagnostic test to assess voiding dysfunction, concerns exist regarding the use of a single uroflow test for clinical decision making.
Presented by Harris Emilio Foster, MD
Miami, FL (UroToday.com) Dr. Foster leads the audience through the AUA BPH Guidelines briefly emphasizing the new changes /updates that will be seen in the new updated BPH guidelines.